Pulmonary Vascular Disease News

NASHVILLE, Tenn. — Initiation of oral selexipag within 12 months of pulmonary arterial hypertension diagnosis may reduce all-cause hospitalizations and overall medical costs, according to a new analysis.

In 2020, there was an increase in pulmonary embolism-related mortality not limited only to patients with confirmed SARS-CoV-2 infection, according to a research letter published in the Journal of the American College of Cardiology.

Patients with pulmonary hypertension associated with interstitial lung disease had better outcomes with a higher dose of inhaled treprostinil, as compared with a lower dose or placebo, according to a study.

In a cohort of patients with chronic precapillary pulmonary hypertension, the rates of in-hospital mortality for those who contracted COVID-19 were more than 40%, according to a study.

Adjusting pulmonary hemodynamics for esophageal pressure in patients with obesity and high pulmonary artery wedge pressure reduced the risk for postcapillary pulmonary hypertension diagnosis, according to findings published in Chest.

BOSTON — In patients with intermediate- and high-risk pulmonary embolism, mechanical thrombectomy was safe and linked with good short-term hemodynamic and clinical outcomes, according to data from the FLASH registry.

BOSTON — Pulmonary artery denervation improved exercise capacity and measures of cardiac function vs. a sham procedure in patients with WHO group 1 pulmonary arterial hypertension, speaker reported.

BOSTON — Pulmonary artery denervation improved exercise capacity and measures of cardiac function vs. a sham procedure in patients with WHO group 1 pulmonary arterial hypertension, speaker reported.

Viz.ai announced it received FDA 510(k) clearance for its automated right ventricle/left ventricle ratio algorithm for use in patients with suspected pulmonary embolism.

Multidisciplinary and tailored management of pulmonary arterial hypertension in pregnancy that emphasizes optimized right heart function before birth may lead to better clinical outcomes in a referral pulmonary hypertension center.